Metropolis Healthcare Q2 Results: Surendran Chemmenkotli On Margins, 23% Revenue Growth & Radiology #ETNOW
Metropolis Healthcare Q2 Results: Surendran Chemmenkotli On Margins, 23% Revenue Growth & Radiology
Metropolis Healthcare reports a solid 23% YoY revenue and 13% profit growth in Q2, with EBITDA up 20% despite margin pressure. MD Surendran Chemakotai tells ET NOW how seasonal uptick, cost optimization, and acquisition efficiency drove performance. He shares outlook on FY26 guidance, organic vs inorganic growth, and plans for radiology expansion across key cities.
#etnow #metropolishealth #healthcare #q2earnings #q2result #businessnews #topnews #sharemarkettips
control your money with economic times now.
YouTube Channel – https://www.youtube.com/@ETNow
Subscribe To ET Now For Latest Updates On Stocks Market News , Business News, Company News, IPO & More | https://bit.ly/SubscribeToETNow
Subscribe Now To Our Network Channels :-
ET Now Swadesh: https://www.youtube.com/etnowswadesh
Times Now: http://goo.gl/U9ibPb
Social Media Links :-
Twitter – http://goo.gl/hA0vDt
Facebook – http://goo.gl/5Lr4mC
Website – https://ift.tt/po3ymB8
Follow us on Google News for latest updates
ET Now: https://ift.tt/E3jAx7G
Times Now Navbharat: https://bit.ly/3zDaKJo
Times Now : https://bit.ly/3CyrrYg
Zoom: https://bit.ly/3CEK0dv
Chapters:
0:00 Market Overview: Nifty Trends and Earnings Season Insights
0:30 Metropolitan Healthcare Earnings Report: Key Highlights
1:12 Understanding Margin Drivers: Revenue Growth and Cost Optimization
2:40 Future Guidance: Patient Volume and Revenue Growth Expectations
3:34 Expansion Plans: Funding High-End Radiology Without Margin Impact
Thank you for your support in keeping this website running.💛
View on “Tokyo Trend News”
コメントを送信